To view this email as a web page, click here.

Incorporating a chemotherapy-free interval in metastatic colorectal cancer

Tuesday, December 15, 2020 • 8:00 pm EST

What is the rationale and strategy for implementing chemotherapy-free intervals for patients with metastatic colorectal cancer? Join us as our panel of experts discuss this critical topic and answer your questions.

Expert insights provided by:

MODERATOR John L. Marshall, MD Director, The Ruesch Center for the Cure of GI Cancers Frederick P. Smith Endowed Chair Chief, Hematology and Oncology Lombardi Comprehensive Cancer Center Georgetown University Medical Center SPEAKER Axel Grothey, MD Director, GI Cancer Research West Cancer Center and Research Institute Medical Director, OneR OneOncology

Attend this event to have a greater understanding on how to:

Identify unmet needs in the treatment of metastatic colorectal cancer Discuss the role of chemotherapy-free intervals in the context of lifelong therapy for patients with metastatic colorectal cancer Review relevant clinical trial data and its implications for practice in metastatic colorectal cancer

We hope you can join us and please forward this email to any colleagues who may be interested in this event.

Sponsored by

This email was sent by: %%Member_Busname%% %%Member_Addr%%, %%Member_City%%, %%Member_State%%, %%Member_PostalCode%% %%Member_Country%% Privacy Policy Update Profile      Manage Subscriptions      Unsubscribe